BRIGHTON PATRICK: Open Payments
NPI 1538698162 · MONROE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 42 payments from 27 companies in 2025. Trend: 2023 $997 · 2024 $1,144 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| ABBVIE INC. | 5 | $110 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Astellas Pharma US Inc | 2 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Incyte Corporation | 2 | $54 |
| PharmaEssentia USA Corporation | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Iovance Biotherapeutics, Inc. | 1 | $31 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
Products named: VENCLEXTA, KISQALI, KEYTRUDA, Vyloy, Onivyde, BESREMI, Amtagvi, PROVENGE.
Industry payments across GA — which companies pay providers there.
